Tessa V. van der Hoeven

The HepaRG cell line is suitable for bioartificial liver application

Ruurdtje Hoekstra, Geert A. A. Nibourg, Tessa V. van der Hoeven et al. · The International Journal of Biochemistry & Cell Biology · 2011 · 77 citations

Hepatology, Heparg Cell Line, Liver Physiology +13

Life spanning murine gene expression profiles in relation to chronological and pathological aging in multiple organs

Martijs J. Jonker, Joost P.M. Melis, Raoul Kuiper et al. · Aging Cell · 2013 · 66 citations · Full text

Chronological Aging, Lifespan Extension, Systems Biology +14

Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure

Geert A. A. Nibourg, Robert A.F.M. Chamuleau, Tessa V. van der Hoeven et al. · PLoS ONE · 2012 · 60 citations · Full text

Dmso Treatment, Cirrhosis, Oxidative Stress +21

Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver

P.P.C. Poyck, Albert C.W.A. van Wijk, Tessa V. van der Hoeven et al. · Journal of Hepatology · 2007 · 55 citations

Hepatology, Liver Physiology, Bioartificial Liver +9

The Absence of Ser389 Phosphorylation in p53 Affects the Basal Gene Expression Level of Many p53-Dependent Genes and Alters the Biphasic Response to UV Exposure in Mouse Embryonic Fibroblasts

Wendy Bruins, Oskar Bruning, Martijs J. Jonker et al. · Molecular and Cellular Biology · 2008 · 34 citations · Full text